A nurse is caring for a client who is postpartum and has a prescription for Rho (D) Immunoglobulin. The nurse should verify which of the following prior to administration?

A) Fundal height below the umbilicus:

In the immediate postpartum period, the fundus typically descends at a predictable rate. A fundal height below the umbilicus on the first day postpartum is expected. It is not a cause for immediate intervention unless accompanied by other signs of postpartum hemorrhage.

B) Decreased urge to void:

A decreased urge to void is common in the immediate postpartum period due to perineal swelling, episiotomy or lacerations, and the effects of regional anesthesia. However, it is not an immediate concern as long as the client is voiding adequate amounts of urine.

C) Increased urine output:

Increased urine output in the postpartum period is expected due to the diuretic effect of the body eliminating excess fluid retained during pregnancy. It is not a cause for immediate intervention as long as the client is not exhibiting signs of dehydration.

D) Displaced fundus from the midline:

A displaced fundus from the midline is concerning as it may indicate uterine atony, which is the most common cause of postpartum hemorrhage. Immediate intervention is necessary to prevent further complications such as excessive bleeding.

A) Report of absent breast pain:

Absent breast pain is not a direct indicator of the effectiveness of methylergonovine, which is typically administered to promote uterine contraction and prevent postpartum hemorrhage. Breast pain is more commonly associated with lactation and breastfeeding.

B) Increase in blood pressure:

An increase in blood pressure is not an expected outcome of methylergonovine administration. In fact, methylergonovine can cause transient hypertension as a side effect due to its vasoconstrictive properties.

C) Increase in lochia:

An increase in lochia is not a direct indicator of the effectiveness of methylergonovine. While methylergonovine can promote uterine contractions, leading to expulsion of uterine contents and subsequent decrease in lochia, an increase in lochia might indicate ongoing uterine bleeding or incomplete uterine contraction.

D) Fundus firm to palpation:

The fundus being firm to palpation is the expected outcome of methylergonovine administration. Methylergonovine stimulates uterine contractions, leading to the firming of the uterine fundus. This indicates that the medication is effective in promoting uterine involution and reducing the risk of postpartum hemorrhage.